Loading
Loading…
Loading…
Tender ID
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹1.2 LAccepted-AOC | L1 | Accepted-AOC FIRST LOWEST BIDDER | |
| 2 | L2₹1.5 L+₹32,400 (27.1%)Rejected-AOC 139 141 HIND RAJASTHAN CENTRE DADA SAHEB PHALKE MARG DADAR E MUMBAI 400014 | MUMBAI | MUMBAI | MAHARASHTRA | 400014 | L2 | Rejected-AOC SECOND LOWEST BIDDER |
| Sl No | Description | Qty | Unit | Delpha Drugs and Pharmaceuticals India L2 | Evolution Life International L1 |
|---|---|---|---|---|---|
| 1.00IV DEXTROSE 5%+NACL0.9% | |||||
| 1.01 | IV DEXTROSE 5%+NACL0.9% | 8,000 | Nos | 19 ₹1,52,000 | 14.95 ₹1,19,600 Lowest |
Tender Value
₹2 L
EMD Value
₹4,000
Closing Date
11 Sept 2025, 4:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
CHIEF MEDICAL OFFICER
PT M M M SHATABDI HOSPITAL GOVANDI
IV DEXTROSE NACL
2025_MCGM_1203329_2
HO/2657/CHG DT-03/07/2025
Open Tender
Medicines
Item Rate
30 days
PT.M.M.M.SHATABDI HOSPITAL GOVANDI
Please refer Tender documents.
3 documents required · 3 mandatory
₹429
Yes
₹4,000
Yes
5 Dec 2025
21 Aug 2025
15 Sept 2025
21 Aug 2025
11 Sept 2025
21 Aug 2025
Amount
IV DEXTROSE 5%+NACL0.9%
IV DEXTROSE 5%+NACL0.9%
Delpha Drugs and Pharmaceuticals India (BID ID -6839677)
stage.html
html • 0.04 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
fin_eval.pdf
aoc.pdf
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .